Is BIO or MOH cheaper?

On trailing earnings, BIO is cheaper: BIO trades at a 51.81 P/E and MOH at 1039.74.

Which has grown faster, BIO or MOH?

Over the past five years, MOH grew revenue faster — BIO at a 0.29% CAGR versus MOH at 13.56%.

Is BIO or MOH more profitable?

BIO runs the higher net margin — BIO at 6.52% versus MOH at -0.02%.

Which has been the better investment, BIO or MOH?

Over the past 10-year, MOH delivered the higher annualized total return — BIO at 8.20% versus MOH at 14.05%. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs Molina Healthcare, Inc. (MOH)

BIO leads on 8 of 14 compared metrics.

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Molina Healthcare, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 25, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BIO

Bio-Rad Laboratories, Inc.

$8.50B

$314.46HealthcareAt close: Jul 24, 2026, 4:00 PM ET

MOH

Molina Healthcare, Inc.

$10.31B

$197.55HealthcareAt close: Jul 24, 2026, 4:00 PM ET

Total return — BIO vs MOH

growth of $100 · dividends reinvested · last 23y

BIO +460.0%MOH +1381.6%MOH compounded faster

BIO MOH

BIO vs MOH: by the numbers

•MOH is the larger company ($10.31B vs $8.50B market cap).
•BIO trades at the lower earnings multiple (51.81 vs 1039.74 P/E).
•BIO is profitable (6.52% net margin) while MOH runs a net loss (-0.02%).
•MOH grew revenue faster over the past five years (13.56% vs 0.29% CAGR).

Which is better, BIO or MOH?

Metric tally: BIO 8 · MOH 6

It depends on what you're optimizing for:

ValueBIO(lower P/E)

GrowthMOH(faster 5Y revenue CAGR)

QualityMOH(higher ROIC)

Metrics side by side

Valuation

Metric	BIO	MOH
P/E ratio	51.81●	1039.74
Forward P/E	34.78	—
P/S ratio	3.27	0.23●
P/B ratio	1.24●	2.43
EV / EBITDA	21.36	19.62●
FCF yield	4.21%●	2.67%

Profitability

Metric	BIO	MOH
Gross margin	51.87%●	13.07%
Operating margin	9.25%●	0.66%
Net margin	6.52%●	-0.02%
ROE	2.46%●	-0.17%
ROIC	2.04%	7.64%●

Growth (annualized)

Metric	BIO	MOH
Revenue CAGR (5Y)	0.29%	13.56%●
EPS CAGR (5Y)	-26.27%	-4.78%●
FCF CAGR (5Y)	-7.57%●	-33.88%
Total return CAGR (5Y)	-14.36%	-5.43%●

Frequently asked

Which is better, BIO or MOH?: It depends on your goal. value: BIO (lower P/E); growth: MOH (faster 5Y revenue CAGR); quality: MOH (higher ROIC). Across all compared metrics, BIO leads 8 to 6.
Is BIO or MOH cheaper?: On trailing earnings, BIO is cheaper: BIO trades at a 51.81 P/E and MOH at 1039.74.
Which has grown faster, BIO or MOH?: Over the past five years, MOH grew revenue faster — BIO at a 0.29% CAGR versus MOH at 13.56%.
Is BIO or MOH more profitable?: BIO runs the higher net margin — BIO at 6.52% versus MOH at -0.02%.
Which has been the better investment, BIO or MOH?: Over the past 10-year, MOH delivered the higher annualized total return — BIO at 8.20% versus MOH at 14.05%. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full MOH analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio Molina Healthcare P/E ratio Bio-Rad Laboratories dividend yield Molina Healthcare dividend yield Bio-Rad Laboratories ROE Molina Healthcare ROE Bio-Rad Laboratories operating margin Molina Healthcare operating margin Bio-Rad Laboratories revenue growth Molina Healthcare revenue growth Bio-Rad Laboratories free cash flow Molina Healthcare free cash flow

Bio-Rad Laboratories & Molina Healthcare appear in these rankings

Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 25, 2026.